Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
$0.77
$1.14
$7.79
$72.04M1.36845,024 shsN/A
Bruker Corporation stock logo
BRKR
Bruker
$42.42
-0.1%
$38.88
$34.10
$72.94
$6.43B1.181.71 million shs1.21 million shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.58
+6.0%
$1.14
$0.85
$2.72
$447.13M2.169.84 million shs13.77 million shs
Quanterix Corporation stock logo
QTRX
Quanterix
$6.88
-0.7%
$5.67
$4.05
$16.74
$345.68M1.13603,555 shs383,527 shs
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
0.00%0.00%0.00%0.00%0.00%
Bruker Corporation stock logo
BRKR
Bruker
+1.34%+3.74%+15.60%+12.75%-31.12%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
+15.50%+22.13%+50.87%+25.21%+16.41%
Quanterix Corporation stock logo
QTRX
Quanterix
+3.44%+11.61%+31.81%+11.43%-45.60%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
1.0201 of 5 stars
0.00.00.04.10.62.50.6
Bruker Corporation stock logo
BRKR
Bruker
4.7923 of 5 stars
3.21.01.73.82.75.01.9
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.2614 of 5 stars
3.23.00.00.01.80.01.3
Quanterix Corporation stock logo
QTRX
Quanterix
2.1049 of 5 stars
3.31.00.00.01.13.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
0.00
N/AN/AN/A
Bruker Corporation stock logo
BRKR
Bruker
2.40
Hold$52.8924.68% Upside
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.44
Hold$2.0630.45% Upside
Quanterix Corporation stock logo
QTRX
Quanterix
2.50
Moderate Buy$15.60126.91% Upside

Current Analyst Ratings Breakdown

Latest PACB, BLI, BRKR, and QTRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/26/2025
Bruker Corporation stock logo
BRKR
Bruker
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$61.00 ➝ $50.00
6/25/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$2.00 ➝ $1.50
5/22/2025
Bruker Corporation stock logo
BRKR
Bruker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold$50.00 ➝ $40.00
5/15/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$2.00 ➝ $1.25
5/15/2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$1.80 ➝ $1.80
5/13/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$15.00 ➝ $12.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$57.00 ➝ $45.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$50.00 ➝ $46.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$50.00 ➝ $45.00
5/8/2025
Bruker Corporation stock logo
BRKR
Bruker
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetHold ➝ Hold$57.00 ➝ $48.00
4/30/2025
Quanterix Corporation stock logo
QTRX
Quanterix
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeStrong-Buy ➝ Hold
(Data available from 7/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
$78.60M0.00N/AN/A$2.07 per share0.00
Bruker Corporation stock logo
BRKR
Bruker
$3.37B1.91$3.59 per share11.83$11.85 per share3.58
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$154.01M3.08N/AN/A$1.85 per share0.85
Quanterix Corporation stock logo
QTRX
Quanterix
$137.42M2.50N/AN/A$8.57 per share0.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
-$98.04M-$1.43N/AN/AN/A-124.74%-57.56%-39.40%N/A
Bruker Corporation stock logo
BRKR
Bruker
$113.10M$0.5281.5813.472.852.31%19.47%5.95%8/5/2025 (Estimated)
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$309.85M-$2.79N/AN/AN/A-430.93%-52.07%-15.82%8/6/2025 (Estimated)
Quanterix Corporation stock logo
QTRX
Quanterix
-$38.53M-$1.30N/AN/AN/A-36.82%-15.07%-12.26%8/6/2025 (Estimated)

Latest PACB, BLI, BRKR, and QTRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025
Quanterix Corporation stock logo
QTRX
Quanterix
-$0.69-$0.53+$0.16-$0.53$28.27 million$30.33 million
5/8/2025Q1 2025
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.19-$0.15+$0.04-$1.44$36.90 million$37.15 million
5/7/2025Q1 2025
Bruker Corporation stock logo
BRKR
Bruker
$0.46$0.47+$0.01$0.11$763.83 million$801.40 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
N/AN/AN/AN/AN/A
Bruker Corporation stock logo
BRKR
Bruker
$0.200.47%N/A38.46%N/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/AN/AN/AN/AN/A
Quanterix Corporation stock logo
QTRX
Quanterix
N/AN/AN/AN/AN/A

Latest PACB, BLI, BRKR, and QTRX Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/12/2025
Bruker Corporation stock logo
BRKR
Bruker
quarterly$0.050.5%6/16/20256/16/20256/27/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
0.10
3.89
3.48
Bruker Corporation stock logo
BRKR
Bruker
1.13
1.57
0.74
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
7.05
6.68
5.87
Quanterix Corporation stock logo
QTRX
Quanterix
N/A
8.29
7.53

Institutional Ownership

CompanyInstitutional Ownership
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
68.43%
Bruker Corporation stock logo
BRKR
Bruker
79.52%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
Quanterix Corporation stock logo
QTRX
Quanterix
86.48%

Insider Ownership

CompanyInsider Ownership
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
17.60%
Bruker Corporation stock logo
BRKR
Bruker
27.30%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
2.50%
Quanterix Corporation stock logo
QTRX
Quanterix
6.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Berkeley Lights, Inc. stock logo
BLI
Berkeley Lights
29372.17 million59.47 millionNot Optionable
Bruker Corporation stock logo
BRKR
Bruker
11,396151.53 million110.16 millionOptionable
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
730300.08 million292.58 millionOptionable
Quanterix Corporation stock logo
QTRX
Quanterix
46049.95 million46.51 millionOptionable

Recent News About These Companies

Insider Spends US$1.1m Buying More Shares In Quanterix
Quanterix: Hard To Make A Good Diagnosis

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Berkeley Lights stock logo

Berkeley Lights NASDAQ:BLI

Berkeley Lights, Inc., a digital cell biology company, focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The company offers an integrated platform, which comprise of proprietary consumables, including OptoSelect chips and reagent kits, automation systems, and application and workflow software. It serves in North America, the Asia Pacific, and Europe. Berkeley Lights, Inc. was incorporated in 2011 and is headquartered in Emeryville, California.

Bruker stock logo

Bruker NASDAQ:BRKR

$42.42 -0.04 (-0.09%)
As of 02:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.

Pacific Biosciences of California stock logo

Pacific Biosciences of California NASDAQ:PACB

$1.58 +0.09 (+6.04%)
Closing price 03:57 PM Eastern
Extended Trading
$1.58 0.00 (-0.06%)
As of 04:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Quanterix stock logo

Quanterix NASDAQ:QTRX

$6.88 -0.05 (-0.65%)
Closing price 01:53 PM Eastern
Extended Trading
$6.88 +0.01 (+0.13%)
As of 04:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.